RAHUL KASAN: Open Payments
NPI 1922729821 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,160 in 39 payments from 10 companies in 2025. Trend: 2023 $439 · 2024 $833 · 2025 $1,160
Food & beverage: $1,160
| Company | Payments | Amount |
|---|---|---|
| Forte Bio-Pharma LLC | 4 | $352 |
| Boston Scientific Corporation | 7 | $220 |
| Medtronic, Inc. | 3 | $175 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $172 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
| ABBVIE INC. | 3 | $59 |
| BIOTRONIK NRO, Inc. | 2 | $36 |
| Valinor Pharma, LLC | 2 | $31 |
| Foundation Fusion Solutions, LLC | 1 | $30 |
| Virtus Pharmaceuticals LLC | 1 | $20 |
Products named: PROLATE, INCEPTIV, RELISTOR, General - Pain Management, TANLOR, WaveWriter Alpha Prime 16, XTAMPZA, BOTOX.
Industry payments across GA — which companies pay providers there.
